Scios Inc.
Records under this name other than patents Scios Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,105,819 | Method, Composition and Device for Sampling Natriuretic Peptides in a Biological Fluid Formerly held In force · High confidence | In force | High confidence | |
| US 10,641,781 | Method, Composition and Device for Sampling Natriuretic Peptides in a Biological Fluid Formerly held In force · High confidence | In force | High confidence | |
| US 9,482,677 | Method, Composition and Device for Sampling Natriuretic Peptides in a Biological Fluid Formerly held In force · High confidence | In force | High confidence | |
| US 7,232,824 | Quinazoline derivatives as medicaments Term ended Term ended Feb 27, 2025 · From the USPTO record | Term ended | Term ended Feb 27, 2025 | From the USPTO record |
| US 7,119,199 | Process for the preparation of pyridopyrimidones Term ended Term ended Dec 31, 2024 · From the USPTO record | Term ended | Term ended Dec 31, 2024 | From the USPTO record |
| US 7,223,766 | Bi-cyclic pyrimidine inhibitors of TGFβ Term ended Term ended Dec 22, 2024 · From the USPTO record | Term ended | Term ended Dec 22, 2024 | From the USPTO record |
| US 7,393,851 | Azaindole derivatives as inhibitors of p38 kinase Term ended Term ended Nov 23, 2024 · From the USPTO record | Term ended | Term ended Nov 23, 2024 | From the USPTO record |
| US 7,244,441 | Stents and intra-luminal prostheses containing map kinase inhibitors Term ended Term ended Sep 27, 2024 · From the USPTO record | Term ended | Term ended Sep 27, 2024 | From the USPTO record |
| US 7,220,763 | Indole-type derivatives as inhibitors of p38 kinase Term ended Term ended Sep 9, 2024 · From the USPTO record | Term ended | Term ended Sep 9, 2024 | From the USPTO record |
| US 7,268,139 | Methods of promoting osteogenesis Formerly held Term ended Term ended Nov 25, 2023 · From the USPTO record | Term ended | Term ended Nov 25, 2023 | From the USPTO record |